Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 15 results.
User Information
Export Records
  1. 1.   Repression of ZNFX1 by LncRNA ZFAS1 mediates tobacco-induced pulmonary carcinogenesis
  2. Xi, Sichuan; Shan, Jigui; Wu, Xinwei; Wang, Haitao; Zhang, Mary R; Oyetunji, Shakirat; Xu, Hong; Xiao, Zuoxiang; Tolunay, Tuana; Carr, Shamus R; Hoang, Chuong D; Schrump, David S
  3. Cellular & Molecular Biology Letters. 2025, Apr 10; 30(1): 44.
  1. 2.   Genome-wide Screens Identify Lineage- and Tumor-Specific Genes Modulating MHC-I- and MHC-II-Restricted Immunosurveillance of Human Lymphomas
  2. Dersh, Devin; Phelan, James D; Gumina, Megan E; Wang, Boya; Arbuckle, Jesse H; Holly, Jaroslav; Kishton, Rigel J; Markowitz,Tovah; Seedhom, Mina O; Fridlyand, Nathan; Wright, George W; Huang, Da Wei; Ceribelli, Michele; Thomas, Craig J; Lack,Justin; Restifo, Nicholas P; Kristie, Thomas M; Staudt, Louis M; Yewdell, Jonathan W
  3. Immunity. 2021, Jan 12; 54(1): 116-131.e10.
  1. 3.   An EZH2 polymorphism is associated with clinical outcome in metastatic colorectal cancer patients
  2. Crea, F.; Fornaro, L.; Paolicchi, E.; Masi, G.; Frumento, P.; Loupakis, F.; Salvatore, L.; Cremolini, C.; Schirripa, M.; Graziano, F.; Ronzoni, M.; Ricci, V.; Farrar, W. L.; Falcone, A.; Danesi, R.
  3. Annals of Oncology. 2012, May; 23(5): 1207-1213.
  1. 4.   PRC2 directly methylates GATA4 and represses its transcriptional activity
  2. He, A. B.; Shen, X. H.; Ma, Q.; Cao, J. J.; von Gise, A.; Zhou, P. Z.; Wang, G.; Marquez, V. E.; Orkin, S. H.; Pu, W. T.
  3. Genes & Development. 2012, Jan; 26(1): 37-42.
  1. 5.   EZH2 Mediates Epigenetic Silencing of Neuroblastoma Suppressor Genes CASZ1, CLU, RUNX3, and NGFR
  2. Wang, C. X.; Liu, Z. H.; Woo, C. W.; Li, Z. J.; Wang, L. F.; Wei, J. S.; Marquez, V. E.; Bates, S. E.; Jin, Q. H.; Khan, J.; Ge, K.; Thiele, C. J.
  3. Cancer Research. 2012, Jan; 72(1): 315-324.
  1. 6.   Epigenetic regulation of CIITA expression in human T-cells
  2. van Eggermond, M.; Boom, D. R.; Klous, P.; Schooten, E.; Marquez, V. E.; Wierda, R. J.; Holling, T. M.; van den Eisen, P. J.
  3. Biochemical Pharmacology. 2011, Nov; 82(10): 1430-1437.
  1. 7.   Faithful Markers of Circulating Cancer Stem Cells: Is CD133 Sufficient for Validation in Clinics?
  2. Crea, F.; Fornaro, L.; Masi, G.; Falcone, A.; Danesi, R.; Farrar, W.
  3. Journal of Clinical Oncology. 2011, Sep; 29(25): 3487-3488.
  1. 8.   Overexpression of enhancer of zeste homolog 2 with trimethylation of lysine 27 on histone H3 in adult T-cell leukemia/lymphoma as a target for epigenetic therapy
  2. Sasaki, D.; Imaizumi, Y.; Hasegawa, H.; Osaka, A.; Tsukasaki, K.; Choi, Y. L.; Mano, H.; Marquez, V. E.; Hayashi, T.; Yanagihara, K.; Moriwaki, Y.; Miyazaki, Y.; Kamihira, S.; Yamada, Y.
  3. Haematologica-the Hematology Journal. 2011, May; 96(5): 712-719.
  1. 9.   Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancer
  2. Crea, F.; Hurt, E. M.; Mathews, L. A.; Cabarcas, S. M.; Sun, L.; Marquez, V. E.; Danesi, R.; Farrar, W. L.
  3. Molecular Cancer. 2011, Apr; 10: 10.
  1. 10.   Methotrexate induces apoptosis through p53/p21-dependent pathway and increases E-cadherin expression through downregulation of HDAC/EZH2
  2. Huang, W. Y.; Yang, P. M.; Chang, Y. F.; Marquez, V. E.; Chen, C. C.
  3. Biochemical Pharmacology. 2011, Feb; 81(4): 510-517.
  1. 11.   Down-Regulation of miR-101 in Endothelial Cells Promotes Blood Vessel Formation through Reduced Repression of EZH2
  2. Smits, M.; Mir, S. E.; Nilsson, R. J. A.; van der Stoop, P. M.; Niers, J. M.; Marquez, V. E.; Cloos, J.; Breakefield, X. O.; Krichevsky, A. M.; Noske, D. P.; Tannous, B. A.; Wurdinger, T.
  3. Plos One. 2011, Jan; 6(1): 11.
  1. 12.   Dynamic Patterns of Histone Lysine Methylation in the Developing Retina
  2. Rao, R. C.; Tchedre, K. T.; Malik, M. T. A.; Coleman, N.; Fang, Y. A.; Marquez, V. E.; Chen, D. F.
  3. Investigative Ophthalmology & Visual Science. 2010, Dec; 51(12): 6784-6792.
  1. 13.   miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis
  2. Smits, M.; Nilsson, J.; Mir, S. E.; van der Stoop, P. M.; Hulleman, E.; Niers, J. M.; Hamer, P.; Marquez, V. E.; Cloos, J.; Krichevsky, A. M.; Noske, D. P.; Tannous, B. A.; Wurdinger, T.
  3. Oncotarget. 2010, Dec; 1(8): 710-720.
  1. 14.   Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications
  2. Kwon, M. J.; Kim, S. S.; Choi, Y. L.; Jung, H. S.; Balch, C.; Kim, S. H.; Song, Y. S.; Marquez, V. E.; Nephew, K. P.; Shin, Y. K.
  3. Carcinogenesis. 2010, Jun; 31(6): 974-983.
  1. 15.   Integrative genornics analysis reveals silencing of beta-adrenergic signaling by polycomb in prostate cancer
  2. Yu, J.; Cao, Q.; Mehra, R.; Laxman, B.; Yu, J.; Tomlins, S. A.; Creighton, C. J.; Dhanasekaran, S. M.; Shen, R.; Chen, G.; Morris, D. S.; Marquez, V. E.; Shah, R. B.; Ghosh, D.; Varambally, S.; Chinnaiyan, A. M.
  3. Cancer Cell. 2007, Nov; 12(5): 419-431.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel